Regulation & policy

Go East: Inside Asia’s evolving health claims laws

Go East: Inside Asia’s evolving health claims laws

By Shane Starling

The substantiation and transference into law of varying kinds of data backing food supplements, herbal products and other healthy foods remains a major hurdle in evolving Asian food regulations, an expert has said.

Jacked in: The game is up for DMAA products like Jack3D in the UK

UK wins Jack3D appeal and bans DMAA

By Shane Starling

The UK has ended months of ambiguity by banning controversial stimulant DMAA, after its medicines agency won an appeal against a retailer of the most popular brand – USPlabs’ Jack3D.

Bimuno: May be feeling financial discomfort after EFSA rejected its gastro discomfort health claim appeal

EFSA rebuffs prebiotic appeal hopes

By Shane Starling

The European Food Safety Authority (EFSA) health claims panel has given short shrift to an appeal by a Malta-based start-up urging it to revise a 2009 rejection of the prebiotic potential of the company’s proprietary Bimuno formulation.

Germany: DMAA safety data “full of gaps”

DMAA in the dock

Germany: DMAA safety data “full of gaps”

By Shane Starling

The German food safety agency has warned people with increased blood pressure and those suffering from cardiovascular disease off disputed stimulant DMAA, and called for a probe into its legal status.

CSPI takes aim at Welch’s heart healthy claims

CSPI takes aim at Welch’s heart healthy claims

By Caroline Scott-Thomas

The Center for Science in the Public Interest (CSPI) has challenged Welch Foods over its marketing of fruit snacks, fruit cocktails, spreads and juices as ‘heart healthy’ – and Welch’s has rebuffed the accusations, calling them misguided.

Health claim wins drive oral health NPD

Special edition: Oral health

Health claim wins drive oral health NPD

By Shane Starling

Functional gum is the obvious stand-out when it comes to nutrition-focused oral health solutions. Some of these products may be aimed at other health conditions like satiety, but the majority focus on battling dental diseases like periodontitis, caries...

The FDA says firms wishing to make claims about plant sterols and CHD risk reduction should include a minimum of 0.5g of plant sterols per RACC (reference amount customarily consumed) expressed as the weight of nonesterified phytosterols

Smart Balance is hit with lawsuit over plant sterol claims

By Elaine WATSON

Heart-friendly spreads expert Smart Balance has been hit with a class action lawsuit alleging that it does not include enough plant sterols in its spreadable butters to warrant the cholesterol-lowering effects claimed on pack.

Australian medicines agency adds DMAA to poisons list

DMAA in the dock

Australian medicines agency adds DMAA to poisons list

By Shane STARLING

Australia’s medicines regulator – the Therapeutic Goods Administration (TGA) - has added DMAA to its Schedule 9 list of prohibited substances and poisons that includes cannabis, salvia divinorum, GHB, heroin, psilocybin and LSD.

Ireland: bans Jack3D DMAA products as “illegal medicines”

DMAA in the dock

Ireland: DMAA products are “illegal medicines”

By Shane Starling

Ireland has joined the UK, Sweden, Denmark, Finland, Australia, New Zealand, Canada and the US in warning against the pre-workout stimulant DMAA (methylhexaneamine/1,3-dimethylamylamine). 

Astaxanthin wars: Cyanotech and Valensa row over competition, IP

Astaxanthin wars: Cyanotech and Valensa row over competition, IP

By Elaine Watson

Hawaii-based microalgae specialist Cyanotech and Florida-based nutraceutical firm US Nutraceuticals (doing business as Valensa International) have become embroiled in a bitter legal dispute over the potent red antioxidant astaxanthin.

Finland follows Sweden and bans DMAA

DMAA in the dock

Finland follows Sweden and bans DMAA

By Shane Starling

All Nordic nations except Norway have joined the UK in acting against the pre-workout stimulant DMAA, with Sweden and Finland joining Denmark in issuing withdrawal alerts or destroying products.

Speaker Boehner was receptive to Jarrow Formula's concerns about the FDA's NDI draft guidance during a meeting in LA last month, claim its regulatory attorneys

Jarrow calls for Congressional hearings to address NDI guidance woes

By Elaine Watson

Jarrow Formulas has raised its concerns about the FDA’s draft guidance on new dietary ingredients (NDIs) with House Speaker John Boehner as part of its campaign to alert members of Congress to the dangers the “fatally flawed” document presents to the...

Follow us

Products

View more

Webinars